Th is study demonstrated the cytotoxic and cell growth inhibitory eff ect of a bioactive extract of Funalia trogii (Berk.) Bond. et Singer, which was grown in solid-state fermentation at room temperature, on He-La and fi broblast and the mitotic index of lymphocytes. Th e eff ect demonstrated by the bioactive extract of F. trogii on laccase, peroxidase, SOD, ascorbate peroxidase, catalase, and glutation peroxidase is shown in Table 1. A study on the possible cytotoxic and cell growth inhibitory eff ects of the bioactive extracts of two white-rot fungi showed that these extracts had signifi cant cytotoxic and antiproliferative properties on the HeLa cancer cell line. Hence, the aim of this study was to examine the in vitro cytotoxic activities of standardized aqueous bioactive extracts prepared from Funalia trogii on HeLa and fi broblast cell lines using a MTT (3-[4,5-Dimetiltiazol-2-]-2-5-difeniltetrazolium bromide) cytotoxicity assay. F. trogii solutions were found to exhibit cytotoxic eff ects on HeLa cell lines. Based on the data, it was found that toxicity ratios of 0.05 µL of F. trogii extract solutions were 71.5%. Furthermore, F. trogii extract solutions were also cytotoxic on fi broblast cell lines.
Analysis of the data indicated that the toxicity ratio of 0.05 µL of F. trogii solutions was 51.3%.
Th ese results showed that the extracts had a substantial cytotoxic action on HeLa cell lines but less on fi broblast cells. In separate experiments the mitotic index reached nearly the same value at 4 µg/mL MMC, 75 µL concentrations of non-heated fungal extract. Th erefore, in order to compare the mutagenic potential of fungal extract and MMC, we used concentration values in SCE analysis. Table  2 represents the SCE frequency of cultures treated with non-heated fungal extract, positive control, and negative controls. A signifi cant induction of SCE was observed in cultured lymphocytes treated with MMC (4 µg/mL) compared with non-heated fungal extract and negative control (p < 0.001). Th ere was no signifi cant diff erence between negative control and non-heated fungal extract (p > 0.05, p = 0.73). In conclusion, we did not observe any genotoxic eff ect.
In bioactive extracts of fungi, we revealed the determination of enzyme or enzymes responsible for cytotoxic eff ect on HeLa cell line. As a result, antitumor activitiy was shown by two enzymes-laccase and peroxidase-produced by fungi. Bioactive extracts have natural quinone substances from lignin by production of peroxidase and laccase. Th ese enzymes acted more selectively on HeLa cells, arresting the cell in the G-phase of the cell cycle and inducing apoptosis. Th e basis of our work was that bioreductive activation was also a highly specifi c delivery mechanism for targeting a variety of processes and was important for tumor growth. Th us, bioreduction of a quinone in the hypoxic region of a tumor would result in the formation of an intermediate semiquinone or hydroquinone (depending on 1-e or 2-e reduction). Hence, we proved that the covalent bond in quinone is metabolically stable, the eff ector quinone substance is only released within the hypoxic regions of tumors, and the desired large diff erential between the eff ects of the quinone is attained. We are able to produce the quinones naturally, which can act as excellent subtrates for NAD(P) H-quinone oxidoreductase (DT-diaphorase) and thus target tumors rich in this enzyme, thereby providing cytotoxic activation by a hypoxia independent mechanism.
Th is study provides evidence for in vitro antitumor activity of a bioactive extract from F. trogii. Th erefore, upon in vivo data, which will follow this study, it may become a promising cytotoxic product for treatment of various types of cancer. 
